{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:14:00Z","timestamp":1791335640437,"version":"4.3.1"},"reference-count":37,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Background: Malignant pleural mesothelioma (MPM) has an infaust prognosis due to resistance to systemic treatment with platin-analoga. MPM cells modulate the immune response to their benefit. They release proinflammatory cytokines, such as TGF-\u00df, awakening resting fibrocytes that switch their phenotype into activated fibroblasts. Signaling interactions between cancer cells and cancer-associated fibroblasts (CAFs) play an integral part in tumor progression. This study aimed to investigate the role CAFs play in MPM progression, analyzing the impact this complex, symbiotic interaction has on kinase-related cell signaling in vitro. Methods: We simulated paracrine signaling in vitro by treating MPM cell lines with conditioned medium (CM) from fibroblasts (FB) and vice versa. NCI-H2052, MSTO-211H, and NCI-H2452 cell lines representing the three mayor MPM subtypes, while embryonal myofibroblast cell lines, IMR-90 and MRC-5, provide a CAFs-like phenotype. Subsequently, differences in proliferation rates, migratory behavior, apoptosis, necrosis, and viability were used as covariates for data analysis. Kinase activity of treated samples and corresponding controls were then analyzed using the PamStation12 platform (PamGene); Results: Treatment with myofibroblast-derived CM revealed significant changes in phosphorylation patterns in MPM cell lines. The observed effect differs strongly between the analyzed MPM cell lines and depends on the origin of CM. Overall, a much stronger effect was observed using CM derived from IMR-90 than MRC-5. The phosphorylation changes mainly affected the MAPK signaling pathway.; Conclusions: The factors secreted by myofibroblasts in fibroblasts CM significantly influence the phosphorylation of kinases, mainly affecting the MAPK signaling cascade in tested MPM cell lines. Our in vitro results indicate promising therapeutic effects by the use of MEK or ERK inhibitors and might have synergistic effects in combination with cisplatin-based treatment, improving clinical outcomes for MPM patients.<\/jats:p>","DOI":"10.3390\/ijms23063278","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:30:14Z","timestamp":1647811814000},"page":"3278","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and Behavior"],"prefix":"10.3390","volume":"23","author":[{"given":"Alexander","family":"Mathilakathu","sequence":"first","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-8646","authenticated-orcid":false,"given":"Michael","family":"Wessolly","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mairinger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Uebner","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, University Hospital Essen\u2014Ruhrlandklinik, University of Duisburg Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kreidt","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9098-8416","authenticated-orcid":false,"given":"Luka","family":"Brcic","sequence":"additional","affiliation":[{"name":"Diagnostic and Research Institute of Pathology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Steinborn","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7527-006X","authenticated-orcid":false,"given":"Kristina","family":"Greimelmaier","sequence":"additional","affiliation":[{"name":"Department of Pathology, Diakonissenkrankenhaus Flensburg, 24939 Flensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremias","family":"Wohlschlaeger","sequence":"additional","affiliation":[{"name":"Department of Pathology, Diakonissenkrankenhaus Flensburg, 24939 Flensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt Werner","family":"Schmid","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian D.","family":"Mairinger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Borchert","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21037\/tlcr.2020.02.01","article-title":"How asbestos and other fibers cause mesothelioma","volume":"9","author":"Gaudino","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2005.04.3190","article-title":"Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma","volume":"24","author":"Ceresoli","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/bjc.2013.368","article-title":"Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma","volume":"109","author":"Ceresoli","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","article-title":"Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: Combined analysis of two phase II trials","volume":"99","author":"Ceresoli","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-10-2873","article-title":"Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed\/carboplatin","volume":"17","author":"Zucali","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lungcan.2004.04.020","article-title":"Chemotherapy for malignant pleural mesothelioma: Past results and recent developments","volume":"45","author":"Tomek","year":"2004","journal-title":"Lung Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bjc.6600673","article-title":"Chemotherapy for malignant pleural mesothelioma: Past results and recent developments","volume":"88","author":"Tomek","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): A multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ceb.2016.05.002","article-title":"Stromal dynamic reciprocity in cancer: Intricacies of fibroblastic-ECM interactions","volume":"42","author":"Alexander","year":"2016","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.critrevonc.2015.09.008","article-title":"Paracrine tumor signaling induces transdifferentiation of surrounding fibroblasts","volume":"97","author":"Heneberg","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e4992","DOI":"10.1371\/journal.pone.0004992","article-title":"Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression","volume":"4","author":"Spaeth","year":"2009","journal-title":"PLoS ONE"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"544789","DOI":"10.3389\/fonc.2020.544789","article-title":"Tumor microenvironment-associated immune-related genes for the prognosis of malignant pleural mesothelioma","volume":"10","author":"Xu","year":"2020","journal-title":"Front Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/excr.2000.4836","article-title":"Serine\/threonine protein kinases and apoptosis","volume":"256","author":"Cross","year":"2000","journal-title":"Exp. Cell Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/ijc.32931","article-title":"Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study","volume":"147","author":"Sirri","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jtho.2016.05.025","article-title":"IL-6 secreted from cancer-associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial-mesenchymal transition signaling","volume":"11","author":"Shintani","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_18","first-page":"1713","article-title":"Anaplastic transition within the cancer microenvironment in early-stage oral tongue squamous cell carcinoma is associated with local recurrence","volume":"53","author":"Okuyama","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41416-019-0705-1","article-title":"The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome","volume":"122","author":"Wu","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_20","first-page":"9","article-title":"Intercellular invasion and the organizational stability of tissues: A role for fibronectin","volume":"1470","author":"Armstrong","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.1951","article-title":"Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche","volume":"15","author":"Ootani","year":"2009","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2017.08.007","article-title":"The stromal niche for epithelial stem cells: A template for regeneration and a brake on malignancy","volume":"32","author":"Roberts","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.yexcr.2010.04.032","article-title":"Activation of fibroblasts in cancer stroma","volume":"316","author":"Vaheri","year":"2010","journal-title":"Exp. Cell Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.21037\/tlcr.2017.04.12","article-title":"In vitro experimental models of mesothelioma revisited","volume":"6","author":"Singh","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1165\/rcmb.2010-0282OC","article-title":"An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury","volume":"45","author":"Shukla","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Brcic, L., Mathilakathu, A., Walter, R.W.H., Wessolly, M., Mairinger, E., Beckert, H., Kreidt, D., Steinborn, J., Hager, T., and Christoph, D.C. (2021). Digital gene expression analysis of epithelioid and sarcomatoid mesothelioma reveals differences in immunogenicity. Cancers, 13.","DOI":"10.3390\/cancers13081761"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1038\/ncomms4472","article-title":"Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","article-title":"Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23-p38 MAPK signalling","volume":"442","author":"Wen","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Braicu, C., Buse, M., Busuioc, C., Drula, R., Gulei, D., Raduly, L., Rusu, A., Irimie, A., Atanasov, A.G., and Slaby, O. (2019). A Comprehensive Review on MAPK: A promising therapeutic target in cancer. Cancers, 11.","DOI":"10.3390\/cancers11101618"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1038\/ncomms7685","article-title":"The nuclear translocation of ERK1\/2 as an anticancer target","volume":"6","author":"Plotnikov","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2045-3701-1-42","article-title":"Partners in crime: The TGF\u03b2 and MAPK pathways in cancer progression","volume":"1","author":"Chapnick","year":"2011","journal-title":"Cell Biosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41590-020-00818-9","article-title":"MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects","volume":"22","author":"Verma","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1158\/1535-7163.MCT-15-0062","article-title":"MEK inhibition overcomes cisplatin resistance conferred by SOS\/MAPK pathway activation in Squamous cell carcinoma","volume":"14","author":"Kong","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12967-018-1471-1","article-title":"Cisplatin based therapy: The role of the mitogen activated protein kinase signaling pathway","volume":"16","author":"Achkar","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1038\/s41598-018-27128-3","article-title":"MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression","volume":"8","author":"Kunita","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7150\/jca.19614","article-title":"The role of cancer-associated fibroblast MRC-5 in pancreatic cancer","volume":"9","author":"Ding","year":"2018","journal-title":"J. Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/6\/3278\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:38:52Z","timestamp":1760135932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/6\/3278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijms23063278"],"URL":"https:\/\/doi.org\/10.3390\/ijms23063278","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]}}}